On June 15, the Vaccines and Related Biological Products Advisory Committee will meet in an open session through an online teleconferencing platform to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age, and als...